Adjuvant Radiotherapy for Early‐Stage Oral Tongue Cancer: Insights From the <scp>NCDB</scp> Based on Grade
These findings validate and extend prior international data, demonstrating a PORT-associated survival benefit in poorly differentiated early-stage OTSCC. The lack of benefit in well- and moderately differentiated tumors underscores the need for individualized treatment approaches. Prospective studies are warranted to refine risk stratification and optimize clinical guidelines.
Authors
- Nina Samuel
- N. Patrik Brodin (ORCID: https://orcid.org/0000-0003-1061-0841)
- Rafi Kabarriti (ORCID: https://orcid.org/0000-0001-7835-718X)
- Bradley A. Schiff (ORCID: https://orcid.org/0000-0002-5860-3627)
- Vikas Mehta (ORCID: https://orcid.org/0000-0002-7991-7422)
- Madhur Garg
- B. Nolasco (ORCID: https://orcid.org/0009-0008-5939-3474)
Institutions
- Albert Einstein College of Medicine (US)
- Montefiore Medical Center (US)
Publication Details
- Journal
- Head & Neck
- Published
- 2025-07-14
- DOI
- https://doi.org/10.1002/hed.28243
- Primary Topic
- Head and Neck Cancer Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00